» Articles » PMID: 36216242

Functional and Structural Characterization of Norovirus GII.6 in Recognizing Histo-blood Group Antigens

Overview
Journal Virol Sin
Specialty Microbiology
Date 2022 Oct 10
PMID 36216242
Authors
Affiliations
Soon will be listed here.
Abstract

Noroviruses (NoVs) are the primary cause of acute gastroenteritis worldwide. Histo-blood group antigens (HBGAs) are receptors or attachment factors that affect the prevalence and host susceptibility of NoVs. GII.6 NoV is one of the predominant genotypes in humans, which recognizes the type ABO secretor of HBGAs. However, the structural basis of GII.6 NoV's interaction with HBGAs receptors remains elusive. In this study, we investigated the binding features of the GII.6 strain to HBGAs using saliva- and glycan-ELISA assays and characterized the molecular basis of the GII.6 virus that recognizes H disaccharide. We showed that the GII.6 ​P domain recognized some A and O secretor's saliva samples, most B secretor's saliva samples, and H disaccharide antigen, but did not bind non-secretors' saliva. Further, we determined the crystal structures of GII.6 and its complex with H disaccharides at 1.7 ​Å, revealing that the P domain of GII.6 shares the conventional binding interface and mode of GII HBGAs. Single residue mutations at the GII.6-H binding sites could inhibit the binding of GII.6 to HBGAs, demonstrating that the interaction residues were crucial in maintaining NoV-glycan integrity. Finally, structural and sequence analyses showed that the major residues of the GII.6-H interaction were conserved among NoVs in the GII genogroup. Taken together, our study characterized the functional and structural features of GII.6 that allow it to interact with HBGAs, and shed light on NoV evolution, epidemiology, and anti-viral drug development.

Citing Articles

Norovirus replication, host interactions and vaccine advances.

Prasad B, Atmar R, Ramani S, Palzkill T, Song Y, Crawford S Nat Rev Microbiol. 2025; .

PMID: 39824927 DOI: 10.1038/s41579-024-01144-9.


Identification of a GII.6 norovirus blockade antibody epitope.

Huo Y, Ma J, Liu J Virus Res. 2023; 334:199168.

PMID: 37392840 PMC: 10410597. DOI: 10.1016/j.virusres.2023.199168.

References
1.
Leshem E, Wikswo M, Barclay L, Brandt E, Storm W, Salehi E . Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012-2013. Emerg Infect Dis. 2013; 19(8):1231-8. PMC: 3739516. DOI: 10.3201/eid1908.130458. View

2.
Qian Y, Song M, Jiang X, Xia M, Meller J, Tan M . Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths. J Virol. 2018; 93(1). PMC: 6288326. DOI: 10.1128/JVI.01655-18. View

3.
Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L . Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003; 9(5):548-53. DOI: 10.1038/nm860. View

4.
Chhabra P, de Graaf M, Parra G, Chan M, Green K, Martella V . Updated classification of norovirus genogroups and genotypes. J Gen Virol. 2019; 100(10):1393-1406. PMC: 7011714. DOI: 10.1099/jgv.0.001318. View

5.
Sun X, Li D, Peng R, Guo N, Jin M, Zhou Y . Functional and Structural Characterization of P[19] Rotavirus VP8* Interaction with Histo-blood Group Antigens. J Virol. 2016; 90(21):9758-9765. PMC: 5068527. DOI: 10.1128/JVI.01566-16. View